Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Prostate Cancer After Non-Myeloablative Conditioning
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anti-PSMA transduced T-cells (Primary) ; Interleukin-2
- Indications Prostate cancer
- Focus Adverse reactions
- 17 Jun 2016 Biomarkers information updated
- 18 Sep 2013 New trial record